Aytu BioPharma, Inc. (AYTU)
NASDAQ·Healthcare·Drug Manufacturers - Specialty & Generic
$2.17
-0.91%
Mkt Cap $21.14M
No analyst coverage available
We don't have analyst ratings or price target data for Aytu BioPharma, Inc. yet. Coverage gaps are common for sub-$1B market caps and recently-listed names.